126 related items for PubMed ID: 21928226
41. Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse.
Mahmud S, Jahan S, Hossain MM.
Mymensingh Med J; 2011 Jul; 20(3):402-6. PubMed ID: 21804502
[Abstract] [Full Text] [Related]
42. Treating the idiopathic nephrotic syndrome: are steroids the answer?
Deschênes G, Dossier C, Hogan J.
Pediatr Nephrol; 2019 May; 34(5):777-785. PubMed ID: 29869116
[Abstract] [Full Text] [Related]
43. Effectiveness of a Low Dose Prednisolone Regimen for Treatment of Relapses in Children with Steroid Sensitive Nephrotic Syndrome.
Mantan M, Kansal A, Swarnim S.
Indian J Nephrol; 2022 May; 32(6):588-594. PubMed ID: 36704589
[Abstract] [Full Text] [Related]
44. Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial.
Basu B, Sander A, Roy B, Preussler S, Barua S, Mahapatra TKS, Schaefer F.
JAMA Pediatr; 2018 Aug 01; 172(8):757-764. PubMed ID: 29913001
[Abstract] [Full Text] [Related]
45. A randomized study on a 3-month versus a 7-month prednisolone regimen for the initial episode of childhood idiopathic nephrotic syndrome at a large Saudi center.
Al Talhi A, Al Saran K, Osman ET, Al Shatri A, Osman M, Mirza K.
Int J Pediatr Adolesc Med; 2018 Mar 01; 5(1):18-23. PubMed ID: 30805527
[Abstract] [Full Text] [Related]
46. Single- versus Divided-Dose Prednisolone for the First Episode of Nephrotic Syndrome in Children: An Open-Label RCT.
Khan T, Akhtar S, Mukherjee D, Basu S, Tse Y, Sinha R.
Clin J Am Soc Nephrol; 2023 Oct 01; 18(10):1294-1299. PubMed ID: 37335578
[Abstract] [Full Text] [Related]
47. New lessons from randomized trials in steroid-sensitive nephrotic syndrome: clear evidence against long steroid therapy.
Hoyer PF.
Kidney Int; 2015 Jan 01; 87(1):17-9. PubMed ID: 25549122
[Abstract] [Full Text] [Related]
48. Disease course in steroid sensitive nephrotic syndrome.
Sinha A, Hari P, Sharma PK, Gulati A, Kalaivani M, Mantan M, Dinda AK, Srivastava RN, Bagga A.
Indian Pediatr; 2012 Nov 01; 49(11):881-7. PubMed ID: 22791676
[Abstract] [Full Text] [Related]
49. Behavioural abnormalities in children with new-onset nephrotic syndrome receiving corticosteroid therapy: results of a prospective longitudinal study.
Upadhyay A, Mishra OP, Prasad R, Upadhyay SK, Schaefer F.
Pediatr Nephrol; 2016 Feb 01; 31(2):233-8. PubMed ID: 26416481
[Abstract] [Full Text] [Related]
50. Steroid treatment for the first episode of childhood nephrotic syndrome: comparison of the 8 and 12 weeks regimen using an individual patient data meta-analysis.
Schijvens AM, Teeninga N, Dorresteijn EM, Teerenstra S, Webb NJ, Schreuder MF.
Eur J Pediatr; 2021 Sep 01; 180(9):2849-2859. PubMed ID: 33774744
[Abstract] [Full Text] [Related]
51. Bullous striae distensae.
Gupta V, Yadav S.
Postgrad Med J; 2017 Feb 01; 93(1096):108. PubMed ID: 27496531
[No Abstract] [Full Text] [Related]
52. Use of high-dose prednisolone to overcome rifampicin-induced corticosteroid non-responsiveness in childhood nephrotic syndrome.
Barman H, Dass R, Duwarah SG.
Saudi J Kidney Dis Transpl; 2016 Jan 01; 27(1):157-60. PubMed ID: 26787586
[Abstract] [Full Text] [Related]
53. Ocular complications in children with nephrotic syndrome on long term oral steroids.
Gaur S, Joseph M, Nityanandam S, Subramanian S, Koshy AS, Vasudevan A, Phadke KD, Iyengar A.
Indian J Pediatr; 2014 Jul 01; 81(7):680-3. PubMed ID: 24557606
[Abstract] [Full Text] [Related]
54. Prediction of Risk Factors of Frequent Relapse Idiopathic Nephrotic Syndrome.
Jahan I, Hanif M, Ali MA, Hoque MM.
Mymensingh Med J; 2015 Oct 01; 24(4):735-42. PubMed ID: 26620012
[Abstract] [Full Text] [Related]
55. Comparison of conventional and low dose steroid in the treatment of PFAPA syndrome: preliminary study.
Yazgan H, Gültekin E, Yazıcılar O, Sagun ÖF, Uzun L.
Int J Pediatr Otorhinolaryngol; 2012 Nov 01; 76(11):1588-90. PubMed ID: 22858452
[Abstract] [Full Text] [Related]
56. Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia.
Oyama Y, Fujisawa T, Hashimoto D, Enomoto N, Nakamura Y, Inui N, Kuroishi S, Yokomura K, Toyoshima M, Yamada T, Shirai T, Masuda M, Yasuda K, Hayakawa H, Chida K, Suda T.
Eur Respir J; 2015 Jun 01; 45(6):1624-31. PubMed ID: 25614171
[Abstract] [Full Text] [Related]
57. Effect of prednisolone on linear growth in children with nephrotic syndrome.
Valavi E, Aminzadeh M, Amouri P, Rezazadeh A, Beladi-Mousavi M.
J Pediatr (Rio J); 2020 Jun 01; 96(1):117-124. PubMed ID: 30240629
[Abstract] [Full Text] [Related]
58. Is two month initial prednisolone treatment for nephrotic syndrome inferior to longer duration therapy?
Sinha A, Bagga A, Iyengar A, Mathew JL.
Indian Pediatr; 2014 Oct 01; 51(10):811-7. PubMed ID: 25362013
[No Abstract] [Full Text] [Related]
59. Corticosteroid therapy for steroid-sensitive nephrotic syndrome in children: dose or duration?
Hodson EM, Craig JC.
J Am Soc Nephrol; 2013 Jan 01; 24(1):7-9. PubMed ID: 23243214
[No Abstract] [Full Text] [Related]
60. Extended initial course of prednisolone did not improve clinical outcomes in steroid-sensitive nephrotic syndrome.
Wands D, Reynolds BC.
Arch Dis Child Educ Pract Ed; 2020 Jun 01; 105(3):189. PubMed ID: 31619452
[No Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
